Bryan Abney

Bryan Abney is the Vice President of Quality Assurance and Compliance and a member of the Syner-G team since March 2022. He is an experienced pharmaceutical quality professional with 30 years of progressive experience directing quality control, analytical development and validation, product/process remediation, and quality assurance.

Bryan leads with a team-centric management style and has a history of remediation work improving company/laboratory capabilities and workflow. He builds strong relationships with internal and external stakeholders focusing on team succuss and timely project completion.
Bryan has a track record of project management success achieving customer goals, driving lower costs, and compliance improvement. He has contributed to numerous filings; Executed 1000+ deviation and OOS investigation during remediation activities, designed QMS for 3 companies, 1 patent, 1 poster presentation.

His specialties are: Analytical Chemistry, ICH and FDA guidelines, ANDA, and NDA. And his main areas of expertise are Quality Management Systems (Batch Release, Deviation Systems, Training Programs, CAPA, Material Control, Vendor Qualifications, Records and Documentation, and Change Control), Analytical Chemistry (Quality Control, Method Development, Method Validation and Stability Programs) and Six Sigma Green Belt (Black Belt In Training) (Statistical Process Control, Root Cause Analysis, and Workflow Optimization).

Bryan’s previous experience includes Polypeptide Group, Catalent Pharma Solutions, Sovereign Pharmaceuticals, Jim Beam Brands, Eli Lilly and Company, Kimberly Clark, and Mallinckrodt Medical. His undergraduate and graduate degrees are from: Eastern Kentucky University, and University of Saint Lous, Missouri.